Status:
COMPLETED
Effect of Intracameral Steroids During Phacoemulsification on the Cornea
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Beni-Suef University
Conditions:
Corneal Edema
Eligibility:
All Genders
50-80 years
Phase:
PHASE3
Brief Summary
Prospective, interventional case control study. Sixty-nine eyes were randomized into 3 groups, 23 eyes each : 2groups received intracameral dexamethasone and triamcinolone (TA) respectively, while con...
Detailed Description
Purpose: Investigating the effect of intracameral steroids at the end of phacoemulsification on corneal edema and endothelial count. Methods: Prospective, interventional case control study. Sixty-nin...
Eligibility Criteria
Inclusion
- Cataract grades 2 to 5 nuclear cataract (LOCS III scale)
- uneventful phacoemulsification operation
Exclusion
- extremely hard cataract grade 6 nuclear cataract (LOCS III scale)
- soft cataract
- subluxated lenses or zonular dehiscence
- associated ocular pathology such as glaucoma
- any signs of uveitis
- trauma
- retinal detachment
- vitrectomized or silicone filled eyes
- corneal disease such as Fuch's dystrophy, corneal opacity
- previous refractive corneal surgery
- Cases that developed ruptured posterior capsule and vitreous loss
- those lost to follow up were excluded and randomly replaced by the next chronological patient
Key Trial Info
Start Date :
June 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2020
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT05271058
Start Date
June 16 2019
End Date
August 15 2020
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Khaled G Abueleinen
Giza, Cairo Governorate, Egypt, 12411